%0 Journal Article
%T A recurrent giant cell tumor of bone treated with denosumab
							| Clinics and Practice
%A Klemens Trieb
%A Nicola Stadler
%A Stefan G. Hofstaetter
%A Thomas Fingernagel
%J Clinics and Practice
%D 2015
%R https://doi.org/10.4081/cp.2015.697
%X Although the giant cell tumor of bone is generally classified as a benign tumor it can rarely metastasize and has a potential risk of local recurrence. We want to report about a female patient who suffered from a recurrence of a giant cell tumor of bone after the implantation of a total endoprosthesis of the knee joint. We have treated her with denosumab, which is a receptor activator of nuclear factor kappa-B ligand inhibitor. In this case report we want to present a new option to treat this kind of neoplasm
%K bone
%K denosumab
%K tumor.
%U https://www.clinicsandpractice.org/index.php/cp/article/view/697